News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Insights
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Insights
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
News
Business
Deals
Applied Biosystems Stockholders Approve Merger with Invitrogen Corporation
October 28, 2008
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
NORWALK, Conn.--(BUSINESS WIRE)--Applied Biosystems Inc. (NYSE:ABI) today announced that its stockholders have voted to approve the company’s proposed merger with Invitrogen Corporation (NASDAQ:IVGN) at a special meeting of stockholders held today.
Twitter
LinkedIn
Facebook
Email
Print
Mergers & acquisitions
MORE ON THIS TOPIC
Deals
Novartis puts $772M BioArctic deal on ice, skates away from brain-delivery alliance
November 3, 2026
·
1 min read
·
Gabrielle Masson
Business
Karyopharm files for bankruptcy, looks to merger with Ayrmid for life raft
November 2, 2026
·
3 min read
·
Angela Gabriel
Cell therapy
Cell therapy investment grows as safety events rankle Big Pharma’s CAR T autoimmune push
November 2, 2026
·
3 min read
·
Annalee Armstrong
Earnings
AbbVie’s Q3 beat should keep ‘train rolling’ as company eyes bolt-on deals
October 30, 2026
·
3 min read
·
Gabrielle Masson